Nicotine potentiates morphine antinociception: A possible cholinergic mechanism

European Neuropsychopharmacology

Volumn 6, Issue 2, 1996, Pages 127-133

  Zarrindast, Mohammad Reza ^a   Nami, Atossa Babaei ^a   Farzin, Davood ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antinociception; Cholinergic antagonist; Mice; Morphine; Nicotine; Opioid antagonist

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ATROPINE; HEXAMETHONIUM; MECAMYLAMINE; METERGOLINE; METHYSERGIDE; MORPHINE; NALOXONE; NICOTINE; PHENOXYBENZAMINE; PIMOZIDE; PROPRANOLOL; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST;

EID: 0030070899     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-977X(96)00002-8     Document Type: Article

References (28)

1. Aceto, M.D., Martin, B.R., Tripathi, H.L., May, E.L. and Jacobson, A.E. (1980) Antinociceptive effects of the optically pure stereoisomers of nicotine. Pharmacologist 22, 302.
2. Balfour, D.J.K. (1982) The effects of nicotine on brain neurotransmitters systems. Pharmacol. Ther. 16, 269-282.
3. Chen, G. (1958) The anti-tremorine effect of some drugs as determined by Hoffner's method of testing analgesia in mice. J. Pharmacol. Exp. Ther. 124, 73-76.
4. Chiou, C.Y., Long, J.P., Potrepka, R. and Spratt, J.L. (1970) The ability of various nicotinic agents to release acetylcholine from synaptic vesicles. Arch. Int. Pharmacodyn. 187, 88-96.
5. Christensen, A.V., Arnt, J., Hyttel, J. and Svendsen, O. (1984) Behavioural correlates to the dopamine D-1 and D-2 antagonists. Pol. J. Pharmacol. Pharm. 36, 249-264.
6. Clarke, P.B.S. (1990) Dopaminergic mechanisms in the locomotor stimulant effects of nicotine. Biochem. Pharmacol. 40, 1427-1432.
7. Davenport, K.E., Houdi, A.A. and Van Loon, G.R. (1990) Nicotine protects against mu-opioid receptor antagonism by beta-funaltrexamine: evidence for nicotine-induced release of endogenous opioid in brain. Neurosci. Lett. 113, 40-46.
8. Di Chiara, G., Porceddu, M.L., Vargiu, L, Argiolas, A. and Gessa, G.L. (1976) Evidence for dopamine receptors in the mouse brain mediating sedation. Nature 264, 564-567
9. Eiden, L.E., Giraud, P., Dave, J.R., Hotchkiss, A.J. and Affolter, H.U. (1984) Nicotine receptor stimulation activates enkephalin release and biosynthesis in adrenal chromaffin cells. Nature 312, 661-663.
10. Giorguieff, M.F., Kemel, M.L., Wandscheer, D. and Glowinski, J. (1979) Regulation of dopamine release by presynaptic receptors in rat striatal slices: Effect of nicotine in a low concentration. Life Sci. 25, 1257-1262.
11. 14C-dopamine in rat brain striatum and hypothalamus slices. Neuropharmacology 13, 1025-1032.
12. 3H]-noradrenaline from the hypothalamus. Biochem. Pharmacol. 21, 1829-1838.
13. Houdi, A.A., Pierzchala, K., Marson, L., Palkovits, M. and Van Loon, G.R. (1991) Nicotine-induced alteration in Tyr-Gly-Gly and Metenkephalin in discrete brain nuclei reflects altered enkephalin neuron activity. Peptides 12, 161-166.
14. Hyttel, J. (1983) SCH 23390 the first selective dopamine antagonist. Eur. J. Pharmacol. 91, 153-154.
15. Hyttel, J. (1984) Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390. Neuropharmacology 23, 1395-1401.
16. Imperato, A., Mulas, A. and Di Chiara, G. (1986) Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur. J. Pharmacol. 132, 337-338.
17. Mansner, R. (1972) Relation between some central effects of nicotine and its brain levels in the mouse. Ann. Med. Exp. Biol. Fenn 50, 205-212.
18. Martin, B.R., Tripathi, H.L., Aceto, M.D. and May, E.L. (1983) Relationship of the biodisposition of the stereoisomers of nicotine in the central nervous system to their pharmacological actions. J. Pharmacol. Exp. Ther. 226, 157-163.
19. Molinero, M.T. and Rio, J.D. (1987) Substance P, nicotine acetylcholine receptors and antinociception in the rat. Neuropharmacology 26, 1715-1720.
20. Morley, M.J., Bradshaw, C.M. and Szabadi, E. (1987) Attenuation by pimozide of the suppressant effect of D-amphetamine on operant behaviour. Psychopharmacology 91, 239-243.
21. Nordberg, A., Romanelli, L., Sundwall, A., Bianchi, C. and Beani, L. (1989) Effect of acute and subchronic nicotine treatment on cortical acethylcholine release and on nicotine receptors in rats and guinea-pigs. Br. J. Pharmacol. 98, 71-78.
22. Pasternak, G.W. (1988) Multiple morphine and enkephalin receptors and the relief of pain. J. Am. Med. Assoc. 259, 1362-1367.
23. Pedigo, N.W., Dewey, W.L. and Harris, L.S. (1975) Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice. J. Pharmacol. Exp. Ther. 193, 845-852.
24. Phan, D.V., Doda, M., Bile, A. and Gyorgy, L. (1973) Antinociceptive activity of nicotine. Acta Physiol. Acad. Sci. Hung. 1, 85-93.
25. Sahley, T.L. and Berntson, G.G. (1979) Antinociceptive effects of central and systemic administration of nicotine in the rat. Psychopharmacology 65, 279-283.
26. Stoof, J.C. and Kebabian, J.W. (1984) Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci. 35, 2281-2296.
27. Tripathi, H.L., Martin, B.R. and Aceto, M.D. (1980) Distribution of (+)- and (-)-3H-nicotine in rat brain during induced antinociception. Pharmacologist 22, 303.
28. Tripathi, H.L., Martin, B.R. and Aceto, M.D. (1982) Nicotine induced antinociception in rats and mice: Correlation with nicotine brain levels. J. Pharmacol. Exp. Ther. 221, 91-96.